
About BugSense
Urinary tract infections (UTIs) are among the most common infections globally, affecting 152 million patients worldwide. Differentiated urine diagnostics, which form the basis for adequate therapy, are time-consuming, labor-intensive, and resource-intensive. Incorrect or often unnecessary antibiotic administration prolongs treatment times, increases the risk of complications, and promotes the development of antibiotic resistance. BugSense is developing a paper-based test that is sustainable, affordable, scalable, and user-friendly. The test is designed to reliably identify UTI-causing pathogens in urine and potential antibiotic resistances. The test read-out is performed using a smartphone application and can be conducted from anywhere without requiring a laboratory or specialized personnel.
